胎儿和新生儿溶血性疾病:了解确认致病抗体身份所需的检测

IF 0.1 Q4 OBSTETRICS & GYNECOLOGY
Jeremy Jacobs, Elizabeth Abels
{"title":"胎儿和新生儿溶血性疾病:了解确认致病抗体身份所需的检测","authors":"Jeremy Jacobs, Elizabeth Abels","doi":"10.1055/s-0043-1771524","DOIUrl":null,"url":null,"abstract":"A recent article by Beck et al[1] contributes to our understanding of hemolytic disease of the fetus and newborn (HDFN) mediated by antibodies against non-Rhesus blood group antigen systems. However, there are critical methodological and reporting errors that preclude the ability to draw the conclusions asserted by the authors. First, the authors provide no compelling evidence that the antibody causing the fetal anemia is due to anti-M other than a positive indirect antiglobulin test (IAT) for anti-M in maternal plasma and a coincidentally positive direct antiglobulin test (DAT) on neonatal cells. The authors provide no information regarding plasma studies in the newborn, elution studies, low-incidence antibody testing, or newborn M antigen typing. A positive newborn DAT is nondiagnostic and requires further evaluation, as even a negative maternal IAT does not preclude the possibility of HDFN to a low-incidence maternal alloantibody.[2] Further, contemporary and historical literature of larger case series found that in HDFN caused by anti-M the neonatal DAT is more frequently negative than positive.[2] [3] [4] Therefore, the positive DAT cited by Beck et al could theoretically lower one's suspicion for the cause of HDFN being solely due to anti-M. In addition, when discussing any case of HDFN, but especially with anti-M where the antibody's isotype and reacting temperature can be in question, the testing methods including platform technology, temperature, and enhancement media are vital to the discussion.[5] Beck et al provide no information regarding the antibody identification or titer techniques used in the maternal or neonatal testing nor do the authors provide methodological description of the maternal breast milk testing. Though this case could be an important addition to the growing body of evidence supporting anti-M as a cause of HDFN, further investigation and reporting are required to definitively establish the conclusions proclaimed by the authors.","PeriodicalId":42412,"journal":{"name":"Journal of Fetal Medicine","volume":"52 1","pages":"0"},"PeriodicalIF":0.1000,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody\",\"authors\":\"Jeremy Jacobs, Elizabeth Abels\",\"doi\":\"10.1055/s-0043-1771524\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A recent article by Beck et al[1] contributes to our understanding of hemolytic disease of the fetus and newborn (HDFN) mediated by antibodies against non-Rhesus blood group antigen systems. However, there are critical methodological and reporting errors that preclude the ability to draw the conclusions asserted by the authors. First, the authors provide no compelling evidence that the antibody causing the fetal anemia is due to anti-M other than a positive indirect antiglobulin test (IAT) for anti-M in maternal plasma and a coincidentally positive direct antiglobulin test (DAT) on neonatal cells. The authors provide no information regarding plasma studies in the newborn, elution studies, low-incidence antibody testing, or newborn M antigen typing. A positive newborn DAT is nondiagnostic and requires further evaluation, as even a negative maternal IAT does not preclude the possibility of HDFN to a low-incidence maternal alloantibody.[2] Further, contemporary and historical literature of larger case series found that in HDFN caused by anti-M the neonatal DAT is more frequently negative than positive.[2] [3] [4] Therefore, the positive DAT cited by Beck et al could theoretically lower one's suspicion for the cause of HDFN being solely due to anti-M. In addition, when discussing any case of HDFN, but especially with anti-M where the antibody's isotype and reacting temperature can be in question, the testing methods including platform technology, temperature, and enhancement media are vital to the discussion.[5] Beck et al provide no information regarding the antibody identification or titer techniques used in the maternal or neonatal testing nor do the authors provide methodological description of the maternal breast milk testing. Though this case could be an important addition to the growing body of evidence supporting anti-M as a cause of HDFN, further investigation and reporting are required to definitively establish the conclusions proclaimed by the authors.\",\"PeriodicalId\":42412,\"journal\":{\"name\":\"Journal of Fetal Medicine\",\"volume\":\"52 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2023-10-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Fetal Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/s-0043-1771524\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Fetal Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0043-1771524","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

Beck等人[1]最近发表的一篇文章有助于我们了解针对非恒河猴血型抗原系统的抗体介导的胎儿和新生儿溶血病(hddn)。然而,有关键的方法和报告错误,排除了得出作者断言的结论的能力。首先,作者没有提供令人信服的证据表明,导致胎儿贫血的抗体是由抗m引起的,除了母体血浆中抗m的间接抗球蛋白试验(IAT)阳性和新生儿细胞的直接抗球蛋白试验(DAT)恰好阳性。作者没有提供关于新生儿血浆研究、洗脱研究、低发病率抗体检测或新生儿M抗原分型的信息。新生儿DAT阳性是非诊断性的,需要进一步评估,因为即使母体IAT阴性也不能排除hdn感染低发病率母体同种异体抗体的可能性。[2]此外,当代和历史文献的更大的病例系列发现,在抗- m引起的HDFN中,新生儿DAT阴性多于阳性。[2][3][4]因此,Beck等人引用的阳性DAT理论上可以降低人们对hdf仅由anti-M引起的怀疑。此外,在讨论任何HDFN病例时,特别是在抗体的同型和反应温度存在问题的anti-M时,包括平台技术、温度和增强介质在内的测试方法对讨论至关重要。[5]Beck等人没有提供关于母体或新生儿检测中使用的抗体鉴定或滴度技术的信息,作者也没有提供母体母乳检测的方法学描述。虽然这一病例可能是支持抗m抗体是hdn病因的证据的重要补充,但需要进一步的调查和报告才能明确确立作者所宣布的结论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody
A recent article by Beck et al[1] contributes to our understanding of hemolytic disease of the fetus and newborn (HDFN) mediated by antibodies against non-Rhesus blood group antigen systems. However, there are critical methodological and reporting errors that preclude the ability to draw the conclusions asserted by the authors. First, the authors provide no compelling evidence that the antibody causing the fetal anemia is due to anti-M other than a positive indirect antiglobulin test (IAT) for anti-M in maternal plasma and a coincidentally positive direct antiglobulin test (DAT) on neonatal cells. The authors provide no information regarding plasma studies in the newborn, elution studies, low-incidence antibody testing, or newborn M antigen typing. A positive newborn DAT is nondiagnostic and requires further evaluation, as even a negative maternal IAT does not preclude the possibility of HDFN to a low-incidence maternal alloantibody.[2] Further, contemporary and historical literature of larger case series found that in HDFN caused by anti-M the neonatal DAT is more frequently negative than positive.[2] [3] [4] Therefore, the positive DAT cited by Beck et al could theoretically lower one's suspicion for the cause of HDFN being solely due to anti-M. In addition, when discussing any case of HDFN, but especially with anti-M where the antibody's isotype and reacting temperature can be in question, the testing methods including platform technology, temperature, and enhancement media are vital to the discussion.[5] Beck et al provide no information regarding the antibody identification or titer techniques used in the maternal or neonatal testing nor do the authors provide methodological description of the maternal breast milk testing. Though this case could be an important addition to the growing body of evidence supporting anti-M as a cause of HDFN, further investigation and reporting are required to definitively establish the conclusions proclaimed by the authors.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Fetal Medicine
Journal of Fetal Medicine OBSTETRICS & GYNECOLOGY-
自引率
50.00%
发文量
26
期刊介绍: Journal of Fetal Medicine is the official journal of the Society of Fetal Medicine affiliated with International Society of Ultrasound in Obstetrics & Gynecology. This is a peer-reviewed international journal featuring articles with special interest to fetal medicine specialists, geneticists and ulstrasonologists. The aim of the journal is to communicate the results of original research in the field of fetal medicine. It includes a variety of articles suitable for clinicians and scientific specialists concerned with diagnosis and therapy of fetal disorders. All articles on health promotion of the fetus are acceptable for publication. The major focus is on highlighting the work that has been carried out in India and other developing countries. It also includes articles written by experts from the West. Types of articles published: - Original research articles related to fetal care and basic research - Review articles - Consensus guidelines for diagnosis and treatment - Case reports - Images in Fetal Medicine - Brief communications
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信